About Cellino
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies. Cellino’s vision is to transform medicine to enhance healthspan for billions across generations.
Company details
Funding
Total raised
$125M
Last stage
Series A
Investors
Founders
Nabiha Saklayen
PhD from Harvard; pioneered cellular laser editing technology; named MIT Tech Review Innovator Under 35 and EY Entrepreneur of the Year 2025 New England.
LinkedInMarinna Madrid
PhD from Harvard; nanofabrication expert; joined Cellino's Board of Directors in January 2026.
LinkedInMatthias Wagner
Veteran founder and technologist who co-founded Cellino in 2017 alongside Saklayen and Madrid.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.